RHONDA ROBINSON: Open Payments
NPI 1003419771 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,568 in 66 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $507 · 2025 $1,568
Food & beverage: $1,568
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $715 |
| JAZZ PHARMACEUTICALS INC. | 17 | $327 |
| SK Life Science, Inc. | 14 | $291 |
| Aucta Pharmaceuticals, Inc. | 8 | $143 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $39 |
| Alexion Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Biogen, Inc. | 1 | $15 |
Products named: Fintepla, EPIDIOLEX, Motpoly XR, Briviact, Nayzilam, FYCOMPA, ULTOMIRIS, WAINUA.
Industry payments across TX — which companies pay providers there.
